Group One Trading’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
HAIM
YAG
WN
VF
MAWA
IWA
BCM
Group One Trading's TRIB Position: Q4 2023 in Review
Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 3,338 shares — an estimated $12.2K sold.
Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.
- Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 3,338 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
- Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
- Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
- 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.